an AD submission anywhere else than the FDA is our truly best shot on goal.
100% on that. When we learned that the AD application in Europe would be the first order of business toward regulatory approval, I was both surprised and happy. I posted at the time that I thought that approach by Missling was a great strategy since so many of the U.S. three-letter agencies have proven to be compromised and corrupt.